Emerging evidence for the use of colchicine for secondary prevention of coronary heart disease.

Authors:
Nidorf SM; Layland J; Robinson PC; Patel S; Psaltis PJ and 1 more

Journal:
Med J Aust

Publication Year: 2022

DOI:
10.5694/mja2.51488

PMCID:
PMC9543631

PMID:
35393699

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Med J Aust

Abbreviation: Med J Aust

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Access to voluntary assisted dying in Australia requires fair remuneration for medical practitioner…
Haining CM; Willmott L; Towler S and 1 more (2022) - Transparency Score: 3/6
A planetary health-organ system map to integrate climate change and health content into medical cur…
Burch H; Beaton LJ; Simpson G and 3 more (2022) - Transparency Score: 2/6
A polymorphic rash from across the seas.
Flora A; Garg P; Cheung K and 2 more (2022) - Transparency Score: 2/6
Assessing the value of precision medicine health technologies to detect and manage melanoma.
Mahumud RA; Janda M; Soyer HP and 3 more (2022) - Transparency Score: 3/6
Associations between COVID-19 and hospitalisation with respiratory and non-respiratory conditions: …
Rowe SL; Leder K; Dyson K and 10 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests Aspen Pharmacare Australia provided colchicine and matching placebo for the Australian arm of the LoDoCo2 trial."

Evidence found in paper:

"We have received funding from the Australian Government Department of Health, the National Health and Medical Research Council (GNT0211980, GNT0353669, GNT1088455, GNT1127159, GNT1187193), and the Sir Charles Gairdner Hospital Research Advisory Committee (NM 2014). Open access publishing facilitated by The University of Western Australia, as part of the Wiley ‐ The University of Western Australia agreement via the Council of Australian University Librarians."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025